Enabling informed decision making
With over 40 years of experience in health economics research, IHE is thorough and accurate but also fast and efficient in its contribution to a range of endeavors to improve public health. Through high quality research, we provide evidence-based support for informed decision making for health and welfare. What can we do for you?
Our recent IHE Reports
Vad får framtidens läkemedel kosta och vad kan de ge i besparingar?
Comparator Report on Cancer in Europe 2025 – Disease Burden, Costs and Access to Medicines and Molecular Diagnostics
An analysis of behaviour, health, and GDP during the Covid-19 pandemic in Europe
-
Some of our areas of expertise
Cancer
IHE has many years of experience of health economic studies in the therapeutic area of dermatology and far-reaching collaboration with the national quality registry for psoriasis (PsoReg).
-
Some of our areas of expertise
Diabetes
IHE has a broad experience of health economic studies in diabetes, both Type I and Type II. Among other things, IHE has provided health economic expertise in the development of the National Board of Health and Welfare's national diabetes guidelines.
-
Some of our areas of expertise
Dermatology
IHE has many years of experience of health economic studies in the therapeutic area of dermatology and far-reaching collaboration with the national quality registry for psoriasis (PsoReg).
Our recent publications
The association between non‑motor symptoms and cost in Parkinson’s disease
A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care
